Previous 10 | Next 10 |
Atomera (NASDAQ: ATOM ) -14% on launch of stock offering. More news on: Atomera Incorporated, Infinera Corporation, Veeco Instruments Inc., Stocks on the move, , Read more ...
Capricor Therapeutics (NASDAQ: CAPR ) announces topline results from a Phase 2 clinical trial, HOPE-2 , evaluating lead candidate CAP-1002 in patients with advanced Duchenne muscular dystrophy (DMD). More news on: Capricor Therapeutics, Inc., Healthcare stocks news, Stocks on the move, ...
-One-Year Results from Randomized, Double-Blind, Placebo-Controlled Study Demonstrate Improved Performance of Upper Limb (PUL) 2.0 (p=0.05)- -First Ever Study in DMD that Correlates Stabilization in Cardiac Function with a Reduction in a Biomarker of Cell Damage- -Company Plannin...
The SARS-CoV2 pandemic has ignited a massive effort across the globe, led by medical researchers and biotech companies, to come up with therapies that can help patients and bring an end to the pandemic. Vaccines, antibodies, immunity and convalescent plasma have all become common medical ter...
Hertz Global Holdings (NYSE: HTZ ) -16% after it enters into forbearances and limited waivers . More news on: Hertz Global Holdings, Inc., Centennial Resource Development, Inc., Compass Diversified Holdings LLC, Stocks on the move, , Read more ...
Gainers: Medigus (NASDAQ: MDGS ) +44% . More news on: Medigus Ltd., Indonesia Energy Corporation Limited, National Holdings Corporation, Stocks on the move, , Read more ...
Gainers: ThermoGenesis (NASDAQ: THMO ) +82% . More news on: ThermoGenesis Holdings, Inc., Summer Infant, Inc., Midatech Pharma plc, Stocks on the move, , Read more ...
Chesapeake Energy (NYSE: CHK ) -43% after preparing bankruptcy filing. More news on: Chesapeake Energy Corporation, On Deck Capital, Inc., Capricor Therapeutics, Inc., Stocks on the move, , Read more ...
Gainers: Capricor Therapeutics (NASDAQ: CAPR ) +248% . More news on: Capricor Therapeutics, Inc., Chimerix, Inc., Sientra, Inc., Stocks on the move, , Read more ...
Nano cap Capricor Therapeutics ( CAPR +180.5% ) is up big on a whopping 69x surge in volume in reaction to new data on lead candidate CAP-1002, an off-the-shelf cardiac cell therapy, in severely ill COVID-19 patients. More news on: Capricor Therapeutics, Inc., Healthcare stocks news, S...
News, Short Squeeze, Breakout and More Instantly...
Capricor Therapeutics Inc. Company Name:
CAPR Stock Symbol:
NASDAQ Market:
Capricor Therapeutics Inc. Website:
SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is set to join the Russell 2000 ® Index an...
-Results in Performance of the Upper Limb (PUL v2.0) Continue to Show Slowing of Disease Progression in Later-Stage DMD Patients- -Improvements Seen in Multiple Cardiac Endpoints Demonstrating Stabilization of Cardiac Function Over 3 Years of Treatment- -Pre-BLA Meeting with FDA...
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- In a release issued under the headline "Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy" on Tuesday, June 25th by Capricor Therapeutics, please note that the words "Pre-BLA Meeting with FDA for Deramiocel" were omitted ...